Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine

C Stresemann, F Lyko - International journal of cancer, 2008 - Wiley Online Library
The cytosine analogues 5‐azacytosine (azacytidine) and 2′‐deoxy‐5‐azacytidine
(decitabine) are the currently most advanced drugs for epigenetic cancer therapies. These …

Strategies for development of dengue virus inhibitors

CG Noble, YL Chen, H Dong, F Gu, SP Lim, W Schul… - Antiviral research, 2010 - Elsevier
Antiviral drug discovery is becoming increasingly important due to the global threat of viral
disease pandemics. Many members of the genus Flavivirus are significant human …

Nucleoside transporters: from scavengers to novel therapeutic targets

AE King, MA Ackley, CE Cass, JD Young… - Trends in …, 2006 - cell.com
Hydrophilic purine and pyrimidine nucleosides rely on specialized carrier proteins for their
membrane translocation. The recent identification of two gene families encoding …

The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs

J Zhang, F Visser, KM King, SA Baldwin… - Cancer and Metastasis …, 2007 - Springer
Nucleoside analogs are important components of treatment regimens for various
malignancies. Nucleoside-specific membrane transporters mediate plasma membrane …

Epigenetic cancer therapy: rationales, targets and drugs

M Rius, F Lyko - Oncogene, 2012 - nature.com
The fundamental role of altered epigenetic modification patterns in tumorigenesis
establishes epigenetic regulatory enzymes as important targets for cancer therapy. Over the …

Thymidine analogues for tracking DNA synthesis

BL Cavanagh, T Walker, A Norazit, ACB Meedeniya - Molecules, 2011 - mdpi.com
Replicating cells undergo DNA synthesis in the highly regulated, S-phase of the cell cycle.
Analogues of the pyrimidine deoxynucleoside thymidine may be inserted into replicating …

Nucleoside transporter proteins

M Molina-Arcas, FJ Casado… - Current vascular …, 2009 - ingentaconnect.com
Concentrative nucleoside transporters (CNT; SLC28) and equilibrative nucleoside
transporters (ENT; SLC29) mediate the uptake of natural nucleosides and a variety of …

Intracellular pharmacokinetics of antiretroviral drugs in HIV-infected patients, and their correlation with drug action

C Bazzoli, V Jullien, CL Tiec, E Rey, F Mentré… - Clinical …, 2010 - Springer
In patients infected by HIV, the efficacy of highly active antiretroviral (ARV) therapy through
the blockade of different steps of the retrovirus life cycle is now well established. As HIV is a …

NanoART, neuroAIDS and CNS drug delivery

A Nowacek, HE Gendelman - Nanomedicine, 2009 - Taylor & Francis
A broad range of nanomedicines is being developed to improve drug delivery for CNS
disorders. The structure of the blood–brain barrier (BBB), the presence of efflux pumps and …

microRNAs and acute myeloid leukemia chemoresistance: a mechanistic overview

MM Gabra, L Salmena - Frontiers in oncology, 2017 - frontiersin.org
Up until the early 2000s, a functional role for microRNAs (miRNAs) was yet to be elucidated.
With the advent of increasingly high-throughput and precise RNA-sequencing techniques …